Canada · Health Canada Drug Product Database

BOOSTRIX

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71860
DIN
02247600
Form
Suspension
Company as listed by source
GLAXOSMITHKLINE INC
Source status
Marketed (2007-05-29)
Source last updated
2026-06-29

Source-listed ingredients

  • DIPHTHERIA TOXOID — 2 UNIT — per 0.5 ML
  • TETANUS TOXOID — 20 UNIT — per 0.5 ML
  • PERTUSSIS TOXOID — 8 MCG — per 0.5 ML
  • FILAMENTOUS HAEMAGGLUTININ — 8 MCG — per 0.5 ML
  • PERTACTIN — 2.5 MCG — per 0.5 ML

These values do not establish equivalence or a dose recommendation.

Packages

  • 10x0.5ml (Prefilled Syringe)

Source and coverage

Open Health Canada Drug Product Database

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →